Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome

키워드

참고문헌 (441)

1. Eckel RH, "The metabolic syndrome", Lancet, 365, pp.1415~1428 (2005)
2. Samson SL, "Metabolic syndrome", Endocrinol Metab Clin North Am, 43, pp.1~23 (2014)
3. Dommermuth R, "Metabolic syndrome : systems thinking in heart disease", Prim Care, 45, pp.109~129 (2018)
4. Sperling LS, "The cardiometabolic health alliance : working toward a new care model for the metabolic syndrome", J Am Coll Cardiol, 66, pp.1050~1067 (2015)
5. D'Adamo E, "The possible role of liver steatosis in defining metabolic syndrome in prepubertal children", Metabolism, 59, pp.671~676 (2010)
6. Grundy SM, "Cholesterol gallstones : a fellow traveler with metabolic syndrome", Am J Clin Nutr, 80, pp.1~2 (2004)
7. Després JP, "Abdominal obesity and metabolic syndrome", Nature, 444, pp.881~887 (2006)
8. Gami AS, "Metabolic syndrome and risk of incident cardiovascular events and death : a systematic review and meta-analysis of longitudinal studies", J Am Coll Cardiol, 49, pp.403~414 (2007)
9. Grundy SM, "Metabolic syndrome pandemic", Arterioscler Thromb Vasc Biol, 28, pp.629~636 (2008)
10. Mottillo S, "The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis", J Am Coll Cardiol, 56, pp.1113~1132 (2010)
11. Grundy SM, "Overnutrition, ectopic lipid and the metabolic syndrome", J Investig Med, 64, pp.1082~1086 (2016)
12. Esser N, "Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes", Diabetes Res Clin Pract, 105, pp.141~150 (2014)
13. Esser N, "Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease", Expert Opin Investig Drugs, 24, pp.283~307 (2015)
14. Stenholm S, "Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study", Clin Endocrinol(Oxf), 73, pp.55~65 (2010)
15. Kim LJ, "Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study", Obesity(Silver Spring), 19, pp.1265~1271 (2011)
16. Koster A, "Body fat distribution and inflammation among obese older adults with and without metabolic syndrome", Obesity(Silver Spring), 18, pp.2354~2361 (2010)
17. Després JP, "Abdominal obesity and the metabolic syndrome : contribution to global cardiometabolic risk", Arterioscler Thromb Vasc Biol, 28, pp.1039~1049 (2008)
18. Galassi A, "Metabolic syndrome and risk of cardiovascular disease : a meta-analysis", Am J Med, 119, pp.812~819 (2006)
19. Malik S, "Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults", Circulation, 110, pp.1245~1250 (2004)
20. Rutter MK, "Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study", Diabetes, 54, pp.3252~3257 (2005)
21. Wilson PW, "Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus", Circulation, 112, pp.3066~3072 (2005)
22. Kathiresan S, "Increased small low-density lipoprotein particle number : a prominent feature of the metabolic syndrome in the Framingham Heart Study", Circulation, 113, pp.20~29 (2006)
23. Ford ES, "Prevalence of the metabolic syndrome among US adults : findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)
24. Park YW, "The metabolic syndrome : prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994", Arch Intern Med, 163, pp.427~436 (2003)
25. Ervin RB, "Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006", Natl Health Stat Report, (13), pp.1~7 (2009)
26. McCullough AJ, "Epidemiology of the metabolic syndrome in the USA", J Dig Dis, 12, pp.333~340 (2011)
27. Beltrán-Sánchez H, "Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010", J Am Coll Cardiol, 62, pp.697~703 (2013)
28. Shin D, "Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014", Int J Cardiol, 259, pp.216~219 (2018)
29. Cheung BM, "Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria", J Clin Hypertens(Greenwich), 8, pp.562~570 (2006)
30. Kastorini CM, "Metabolic syndrome and 10-year cardiovascular disease incidence : the ATTICA study", Nutr Metab Cardiovasc Dis, 26, pp.223~231 (2016)
31. Pucci G, "Sex-and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome : a review of the literature", Pharmacol Res, 120, pp.34~42 (2017)
32. Vishram JK, "Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM prospective cohort project", PLoS One, 9, pp.e107294~ (2014)
33. Xi B, "Prevalence of metabolic syndrome and its influencing factors among the Chinese adults : the China Health and Nutrition Survey in 2009", Prev Med, 57, pp.867~871 (2013)
34. Gu D, "Prevalence of the metabolic syndrome and overweight among adults in China", Lancet, 365, pp.1398~1405 (2005)
35. Cheng TO, "Prevalence of metabolic syndrome in Chinese adults has been underestimated by using US-Based National Cholesterol Education Programs Adult Treatment Panel III and World Health Organization criteria", Am J Cardiol, 98, pp.422~423 (2006)
36. He Y, "Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002-2012", Asia Pac J Clin Nutr, 28, pp.621~633 (2019)
37. Prasad DS, "Prevalence and risk factors for metabolic syndrome in Asian Indians : a community study from urban Eastern India", J Cardiovasc Dis Res, 3, pp.204~211 (2012)
38. Katulanda P, "Metabolic syndrome among Sri Lankan adults : prevalence, patterns and correlates", Diabetol Metab Syndr, 4, pp.24~ (2012)
39. Lee SR, "Increased prevalence of metabolic syndrome among hypertensive population : ten years' trend of the Korean National Health and Nutrition Examination Survey", Int J Cardiol, 166, pp.633~639 (2013)
40. Lee SE, "Trends in the prevalence of metabolic syndrome and its components in South Korea : findings from the Korean National Health Insurance Service Database(2009-2013)", PLoS One, 13, pp.e0194490~ (2018)
41. Huh JH, "Metabolic syndrome epidemic among Korean adults : Korean survey of Cardiometabolic Syndrome(2018)", Atherosclerosis, 277, pp.47~52 (2018)
42. Genser L, "Obesity, type 2 diabetes, and the metabolic syndrome : pathophysiologic relationships and guidelines for surgical intervention", Surg Clin North Am, 96, pp.681~701 (2016)
43. Kahn R, "The metabolic syndrome", Lancet, 366, pp.1921~1922 (2005)
44. Kahn R, "The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes", Diabetologia, 48, pp.1684~1699 (2005)
45. Ekelund U, "Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women : the European Prospective Investigation into Cancer and Nutrition Study(EPIC)", Am J Clin Nutr, 101, pp.613~621 (2015)
46. Emili A, "Treating metabolic syndrome : lifestyle change or medication", Can Fam Physician, 53, pp.1203~1205 (2007)
47. Young DR, "Sedentary behavior and cardiovascular morbidity and mortality : a science advisory from the American Heart Association", Circulation, 134, pp.e262~79 (2016)
48. Bozkurt B, "Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure : a scientific statement from the American Heart Association", Circulation, 134, pp.e535~78 (2016)
49. Rader DJ, "Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus", Am J Med, 120(3 Suppl 1), pp.S12~18 (2007)
50. Bamba V, "Obesity and atherogenic dyslipidemia", Gastroenterology, 132, pp.2181~2190 (2007)
51. Haffner SM, "Abdominal adiposity and cardiometabolic risk : do we have all the answers", Am J Med, 120(9 Suppl 1), pp.S10~16 (2007)
52. Bodhini D, "Mediators of insulin resistance & cardiometabolic risk : newer insights", Indian J Med Res, 148, pp.127~129 (2018)
53. Marchesini G, "Nonalcoholic fatty liver disease : a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
54. Neuschwander-Tetri BA, "Fatty liver and the metabolic syndrome", Curr Opin Gastroenterol, 23, pp.193~198 (2007)
55. Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis and the metabolic syndrome", Am J Med Sci, 330, pp.326~335 (2005)
56. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
57. Wang DQ, "Steatosis in the liver", Compr Physiol, 3, pp.1493~1532 (2013)
58. Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis : summary of an AASLD Single Topic Conference", Hepatology, 37, pp.1202~1219 (2003)
59. Banini BA, "Current and future pharmacologic treatment of nonalcoholic steatohepatitis", Curr Opin Gastroenterol, 33, pp.134~141 (2017)
60. American Heart Association, "Diagnosis and management of the metabolic syndrome. An American Heart Association", National Heart, Lung, and Blood Institute scientific statement. Executive summary, 2005, pp.13, 322~327
61. Cruz ML, "The metabolic syndrome in children and adolescents", Curr Diab Rep, 4, pp.53~62 (2004)
62. Cook S, "Prevalence of a metabolic syndrome phenotype in adolescents : findings from the third National Health and Nutrition Examination Survey, 1988-1994", Arch Pediatr Adolesc Med, 157, pp.821~827 (2003)
63. de Ferranti SD, "Prevalence of the metabolic syndrome in American adolescents : findings from the Third National Health and Nutrition Examination Survey", Circulation, 110, pp.2494~2497 (2004)
64. Bokor S, "Prevalence of metabolic syndrome in European obese children", Int J Pediatr Obes 2008;3 Suppl, 2, pp.3~8
65. Weiss R, "Obesity and the metabolic syndrome in children and adolescents", N Engl J Med, 350, pp.2362~2374 (2004)
66. 박진경, "Prevalence of Metabolic Syndrome and Obesity in Adolescents Aged 12 to 19 Years: Comparison between the United States and Korea", Journal of Korean Medical Science, 25(1), pp.75~82 (2010), 대한의학회
67. Park MJ, "Prevalence and trends of metabolic syndrome among Korean adolescents : from the Korean NHANES survey, 1998-2005", J Pediatr, 155, pp.529~534 (2009)
68. Friend A, "The prevalence of metabolic syndrome in children : a systematic review of the literature", Metab Syndr Relat Disord, 11, pp.71~80 (2013)
69. Higgins V, "Pediatric metabolic syndrome : pathophysiology and laboratory assessment", EJIFCC, 28, pp.25~42 (2017)
70. Goodman E, "Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents", J Pediatr, 145, pp.445~451 (2004)
71. Cook S, "The metabolic syndrome : antecedent of adult cardiovascular disease in pediatrics", J Pediatr, 145, pp.427~430 (2004)
72. Agirbasli M, "Metabolic syndrome : bridging the gap from childhood to adulthood", Cardiovasc Ther, 34, pp.30~36 (2016)
73. Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
74. Grundy SM, "Metabolic syndrome : connecting and reconciling cardiovascular and diabetes worlds", J Am Coll Cardiol, 47, pp.1093~1100 (2006)
75. Grundy SM, "A constellation of complications : the metabolic syndrome", Clin Cornerstone, 7, pp.36~45 (2005)
76. Grundy SM, "Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute", Arterioscler Thromb Vasc Biol, 25, pp.2243~2244 (2005)
77. Grundy SM, "Point : the metabolic syndrome still lives", Clin Chem, 51, pp.1352~1354 (2005)
78. Kylin E, "Studien ueber das Hypertonie-Hyperglyka"mie-Hyperurika"miesyndrom", Zentralblatt fuer Innere Medizin, 44, pp.105~127 (1923)
79. Phillips GB, "Sex hormones, risk factors and cardiovascular disease", Am J Med, 65, pp.7~11 (1978)
80. Albrink MJ, "Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population", Lipids, 15, pp.668~676 (1980)
81. Reaven GM, "Banting lecture 1988. Role of insulin resistance in human disease", Diabetes, 37, pp.1595~1607 (1988)
82. Cheal KL, "Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome", Diabetes, 53, pp.1195~1200 (2004)
83. Kim SH, "The metabolic syndrome : one step forward, two steps back", Diab Vasc Dis Res, 1, pp.68~75 (2004)
84. Reaven G, "The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals", Endocrinol Metab Clin North Am, 33, pp.283~303 (2004)
85. Reaven GM, "Insulin resistance, cardiovascular disease, and the metabolic syndrome : how well do the emperor's clothes fit", Diabetes Care, 27, pp.1011~1012 (2004)
86. Grundy SM, "Metabolic syndrome update", Trends Cardiovasc Med, 26, pp.364~373 (2016)
87. Salazar MR, "Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk", Diab Vasc Dis Res, 8, pp.109~116 (2011)
88. Simmons RK, "The metabolic syndrome : useful concept or clinical tool? Report of a WHO Expert Consultation", Diabetologia, 53, pp.600~605 (2010)
89. Reaven GM, "Insulin resistance : the link between obesity and cardiovascular disease", Med Clin North Am, 95, pp.875~892 (2011)
90. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)
91. Balkau B, "Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)", Diabet Med, 16, pp.442~443 (1999)
92. Balkau B, "Insulin resistance: an independent risk factor for cardiovascular disease?", Diabetes Obes Metab, 1(Suppl 1), pp.S23~31 (1999)
93. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults, "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
94. Alberti KG, "Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation", Diabet Med, 23, pp.469~480 (2006)
95. Alberti KG, "The metabolic syndrome--a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
96. Assmann G, "Harmonizing the definition of the metabolic syndrome : comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations", Am J Cardiol, 99, pp.541~548 (2007)
97. Alberti KG, "Harmonizing the metabolic syndrome : a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
98. Zimmet P, "The metabolic syndrome in children and adolescents-an IDF consensus report", Pediatr Diabetes, 8, pp.299~306 (2007)
99. Zimmet P, "The metabolic syndrome in children and adolescents", Lancet, 369, pp.2059~2061 (2007)
100. Ahrens W, "Metabolic syndrome in young children: definitions and results of the IDEFICS study", Int J Obes (Lond), 38(Suppl 2), pp.S4~14 (2014)
101. Koebnick C, "Prevalence of extreme obesity in a multiethnic cohort of children and adolescents", J Pediatr, 157, pp.26~31 (2010)
102. Ebbeling CB, "Childhood obesity : public-health crisis, common sense cure", Lancet, 360, pp.473~482 (2002)
103. Kelly AS, "Severe obesity in children and adolescents : identification, associated health risks, and treatment approaches : a scientific statement from the American Heart Association", Circulation, 128, pp.1689~1712 (2013)
104. Ogden CL, "Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014", JAMA, 315, pp.2292~2299 (2016)
105. Hales CM, "Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016", JAMA, 319, pp.1723~1725 (2018)
106. Ogden CL, "Prevalence of high body mass index in US children and adolescents, 2007-2008", JAMA, 303, pp.242~249 (2010)
107. Hedley AA, "Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002", JAMA, 291, pp.2847~2850 (2004)
108. Ogden CL, "Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010", JAMA, 307, pp.483~490 (2012)
109. Alberti G, "Type 2 diabetes in the young : the evolving epidemic : the international diabetes federation consensus workshop", Diabetes Care, 27, pp.1798~1811 (2004)
110. Daniels SR, "Overweight in children and adolescents : pathophysiology, consequences, prevention, and treatment", Circulation, 111, pp.1999~2012 (2005)
111. Dietz WH, "Overweight children and adolescents", N Engl J Med, 352, pp.2100~2109 (2005)
112. Aguilar M, "Prevalence of the metabolic syndrome in the United States, 2003-2012", JAMA, 313, pp.1973~1974 (2015)
113. Arai H, "Prevalence of metabolic syndrome in the general Japanese population in 2000", J Atheroscler Thromb, 13, pp.202~208 (2006)
114. Saito I, "Prevalence of metabolic syndrome in young men in Japan", J Atheroscler Thromb, 14, pp.27~30 (2007)
115. Moore JX, "Metabolic syndrome prevalence by race", ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012, 2017, pp.14, E24~
116. Adams RJ, "Population comparison of two clinical approaches to the metabolic syndrome : implications of the new International Diabetes Federation consensus definition", Diabetes Care, 28, pp.2777~2779 (2005)
117. Athyros VG, "The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions", Curr Med Res Opin, 21, pp.1157~1159 (2005)
118. Guerrero-Romero F, "Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions", Diabetes Care, 28, pp.2588~2589 (2005)
119. Cornier MA, "The metabolic syndrome", Endocr Rev, 29, pp.777~822 (2008)
120. Lovre D, "Trends in prevalence of the metabolic syndrome", JAMA, 314, pp.950~ (2015)
121. Marchesini G, "WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes", Diabet Med, 21, pp.383~387 (2004)
122. Hu G, "The increasing prevalence of metabolic syndrome among Finnish men and women over a decade", J Clin Endocrinol Metab, 93, pp.832~836 (2008)
123. Ilanne-Parikka P, "Prevalence of the metabolic syndrome and its components : findings from a Finnish general population sample and the Diabetes Prevention Study cohort", Diabetes Care, 27, pp.2135~2140 (2004)
124. Reinehr T, "Comparison of metabolic syndrome prevalence using eight different definitions : a critical approach", Arch Dis Child, 92, pp.1067~1072 (2007)
125. Jørgensen ME, "A comparison between two proposed definitions", Diabet Med, 21, pp.1237~1242 (2004)
126. Császár A, "Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population", Blood Press, 15, pp.101~106 (2006)
127. Liu J, "Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada", Int J Obes(Lond), 30, pp.669~676 (2006)
128. Al-Qahtani DA, "AComparison of the prevalence of metabolic syndrome in Saudi adult females using two definitions", Metab Syndr Relat Disord, 4, pp.204~214 (2006)
129. Balasubramanyam A, "Prevalence of metabolic syndrome and associated risk factors in Asian Indians", J Immigr Minor Health, 10, pp.313~323 (2008)
130. Baracco R, "A comparison of the prevalence of metabolic syndrome and its components in high and low altitude populations in peru", Metab Syndr Relat Disord, 5, pp.55~62 (2007)
131. Alexander CM, "The influence of age and body mass index on the metabolic syndrome and its components", Diabetes Obes Metab, 10, pp.246~250 (2008)
132. Basit A, "Prevalence of metabolic syndrome in Pakistan", Metab Syndr Relat Disord, 6, pp.171~175 (2008)
133. Bee YT Jr, "Prevalence of metabolic syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and modified World Health Organization definitions", Malays J Nutr, 14, pp.65~77 (2008)
134. Caceres M, "Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity", BMC Pediatr, 8, pp.31~ (2008)
135. Calcaterra V, "Prevalence of metabolic syndrome(MS)in children and adolescents with varying degrees of obesity", Clin Endocrinol(Oxf), 68, pp.868~872 (2008)
136. Bener A, "Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria : a population-based study", Metab Syndr Relat Disord, 7, pp.221~229 (2009)
137. Bindraban NR, "A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups", Eur J Epidemiol, 23, pp.37~44 (2008)
138. Caranti DA, "Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents : a comparison study", Int J Clin Pract, 62, pp.1526~1532 (2008)
139. Chien KL, "Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese : a report on the hospital-based health diagnosis of the adult population", Atherosclerosis, 196, pp.764~771 (2008)
140. Churilla JR, "The metabolic syndrome: how definition impacts the prevalence and risk in U.S. adults: 1999-2004 NHANES", Metab Syndr Relat Disord, 5, pp.331~342 (2007)
141. Dhanaraj E, "Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus", J Indian Med Assoc, 106, pp.366~368 (2008)
142. Ekelund U, "Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth", Am J Clin Nutr, 89, pp.90~96 (2009)
143. Erem C, "Prevalence of metabolic syndrome and associated risk factors among Turkish adults : Trabzon MetS study", Endocrine, 33, pp.9~20 (2008)
144. Fiuza M, "Metabolic syndrome in Portugal : prevalence and implications for cardiovascular risk--results from the VALSIM Study English, Portuguese", Rev Port Cardiol, 27, pp.1495~1529 (2008)
145. Malik M, "The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates : a report of a national survey", Metab Syndr Relat Disord, 6, pp.177~186 (2008)
146. Martínez MA, "Metabolic syndrome : prevalence, associated factors, and C-reactive protein : the MADRIC(MADrid RIesgo Cardiovascular)Study", Metabolism, 57, pp.1232~1240 (2008)
147. Matei C, "ROmanian multicentric study of the prevalence of metabolic syndrome--ROMES", Hellenic J Cardiol, 49, pp.303~309 (2008)
148. Sen Y, "Prevalence and risk factors of metabolic syndrome in obese children and adolescents : the role of the severity of obesity", Eur J Pediatr, 167, pp.1183~1189 (2008)
149. 서수진, "The Prevalence of the Metabolic Syndrome in Korean Children and Adolescents: Comparisons of the Criteria of Cook et al., Cruz and Goran, and Ferranti et al.", Yonsei Medical Journal, 49(4), pp.563~572 (2008), 연세대학교의과대학
150. Shimajiri Y, "Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications", Diabetes Res Clin Pract, 79, pp.310~317 (2008)
151. Yoneda M, "Prevalence of metabolic syndrome compared between native Japanese and Japanese-Americans", Diabetes Res Clin Pract, 79, pp.518~522 (2008)
152. Halley Castillo E, "Body mass index and the prevalence of metabolic syndrome among children and adolescents in two Mexican populations", J Adolesc Health, 40, pp.521~526 (2007)
153. Xu H, "Prevalence of the metabolic syndrome among children from six cities of China", BMC Public Health, 12, pp.13~ (2012)
154. Lucove JC, "Association between adult and childhood socioeconomic status and prevalence of the metabolic syndrome in African Americans : the Pitt County Study", Am J Public Health, 97, pp.234~236 (2007)
155. Chen W, "Path analysis of metabolic syndrome components in black versus white children, adolescents, and adults : the Bogalusa Heart Study", Ann Epidemiol, 18, pp.85~91 (2008)
156. Harville EW, "Is the metabolic syndrome a"small baby"syndrome? : the bogalusa heart study", Metab Syndr Relat Disord, 10, pp.413~421 (2012)
157. Frontini MG, "Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche : the Bogalusa Heart Study", Int J Obes Relat Metab Disord, 27, pp.1398~1404 (2003)
158. Zhang H, "Long-term impact of childhood adiposity on adult metabolic syndrome is modified by insulin resistance : the Bogalusa Heart study", Sci Rep, 5, pp.17885~ (2015)
159. Chen W, "Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk : the Bogalusa Heart Study", Diabetes Care, 28, pp.126~131 (2005)
160. Magnussen CG, "Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone : the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study", Circulation, 122, pp.1604~1611 (2010)
161. Nguyen QM, "Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects : the Bogalusa Heart Study", Diabetes Care, 31, pp.2044~2049 (2008)
162. Srinivasan SR, "Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects : the Bogalusa Heart Study", Hypertension, 48, pp.33~39 (2006)
163. Wang J, "Metabolic syndrome and its associated early-life factors in children and adolescents : a cross-sectional study in Guangzhou, China", Public Health Nutr, 19, pp.1147~1154 (2016)
164. Weiss R, "Prediabetes in obese youth : a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning", Lancet, 362, pp.951~957 (2003)
165. DuBose KD, "Prevalence of the metabolic syndrome in elementary school children", Acta Paediatr, 95, pp.1005~1011 (2006)
166. Invitti C, "Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors", Int J Obes(Lond), 30, pp.627~633 (2006)
167. Kaler SN, "High rates of the metabolic syndrome in a First Nations Community in western Canada : prevalence and determinants in adults and children", Int J Circumpolar Health, 65, pp.389~402 (2006)
168. Kim S, "Prevalence of metabolic syndrome among Korean adolescents according to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation", Nutrients, 8, pp.E588~ (2016)
169. Molnár D, "The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents", Int J Obes Relat Metab Disord, 28(Suppl 3), pp.S70~74 (2004)
170. Papoutsakis C, "Metabolic syndrome in a Mediterranean pediatric cohort : prevalence using International Diabetes Federation-derived criteria and associations with adiponectin and leptin", Metabolism, 61, pp.140~145 (2012)
171. Agredo-Zúñiga RA, "Waist : height ratio, waist circumference and metabolic syndrome abnormalities in Colombian schooled adolescents : a multivariate analysis considering located adiposity", Br J Nutr, 114, pp.700~705 (2015)
172. Bitsori M, "Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype", Int J Pediatr Obes, 4, pp.325~331 (2009)
173. Choi DH, "Usefulness of the waist circumference-to-height ratio in screening for obesity and metabolic syndrome among Korean children and adolescents : Korea National Health and Nutrition Examination Survey, 2010-2014", Nutrients, 9, pp.E256~ (2017)
174. Hirschler V, "Can waist circumference identify children with the metabolic syndrome", Arch Pediatr Adolesc Med, 159, pp.740~744 (2005)
175. McCarthy HD, "Body fat measurements in children as predictors for the metabolic syndrome : focus on waist circumference", Proc Nutr Soc, 65, pp.385~392 (2006)
176. Wu XY, "Higher waist-to-height ratio and waist circumference are predictive of metabolic syndrome and elevated serum alanine aminotransferase in adolescents and young adults in mainland China", Public Health, 126, pp.135~142 (2012)
177. Spolidoro JV, "Waist circumference in children and adolescents correlate with metabolic syndrome and fat deposits in young adults", Clin Nutr, 32, pp.93~97 (2013)
178. Arimura ST, "Waist circumference is better associated with high density lipoprotein(HDL-c)than with body mass index(BMI)in adults with metabolic syndrome", Nutr Hosp, 26, pp.1328~1332 (2011)
179. Zanchetti A, "Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis(ELSA)and its relation with carotid intima-media thickness", J Hypertens, 25, pp.2463~2470 (2007)
180. Cardinal TR, "Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Brazilian adults : baseline analyses of the Longitudinal Study of Adult Health(ELSA-Brasil)", Diabetol Metab Syndr, 10, pp.49~ (2018)
181. Lee WY, "Prevalence of the metabolic syndrome among 40, 698 Korean metropolitan subjects", Diabetes Res Clin Pract, 65, pp.143~149 (2004)
182. Miccoli R, "Prevalence of the metabolic syndrome among Italian adults according to ATP III definition", Nutr Metab Cardiovasc Dis, 15, pp.250~254 (2005)
183. Ali O, "Obesity, central adiposity and cardiometabolic risk factors in children and adolescents : a family-based study", Pediatr Obes, 9, pp.e58~62 (2014)
184. Xi B, "International waist circumference percentile cutoffs for central obesity in children and adolescents aged 6 to 18 years", J Clin Endocrinol Metab, 105, pp.dgz195~ (2020)
185. Mladenova S, "Prevalence of underweight, overweight, general and central obesity among 8-15-years old Bulgarian children and adolescents(Smolyan region, 2012-2014)", Nutr Hosp, 31, pp.2419~2427 (2015)
186. Hosseini M, "Height-adjusted percentiles evaluated central obesity in children and adolescents more effectively than just waist circumference", Acta Paediatr, 106, pp.112~119 (2017)
187. Ejtahed HS, "Utility of waist circumference-to-height ratio as a screening tool for generalized and central obesity among Iranian children and adolescents : the CASPIAN-V study", Pediatr Diabetes, 20, pp.530~537 (2019)
188. Fernández JR, "Changes in pediatric waist circumference percentiles despite reported pediatric weight stabilization in the United States", Pediatr Obes, 12, pp.347~355 (2017)
189. Fernández JR, "Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents", J Pediatr, 145, pp.439~444 (2004)
190. Lee S, "Waist circumference is an independent predictor of insulin resistance in black and white youths", J Pediatr, 148, pp.188~194 (2006)
191. Maffeis C, "Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girls", Eur J Clin Nutr, 57, pp.566~572 (2003)
192. Maffeis C, "Does waist circumference predict fat gain in children", Int J Obes Relat Metab Disord, 25, pp.978~983 (2001)
193. Maffeis C, "Waist circumference and cardiovascular risk factors in prepubertal children", Obes Res, 9, pp.179~187 (2001)
194. Lee S, "Waist circumference, blood pressure, and lipid components of the metabolic syndrome", J Pediatr, 149, pp.809~816 (2006)
195. Cameron AJ, "The metabolic syndrome in Australia : prevalence using four definitions", Diabetes Res Clin Pract, 77, pp.471~478 (2007)
196. de Simone G, "Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes : the Strong Heart Study", Diabetes Care, 30, pp.1851~1856 (2007)
197. Hildrum B, "Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program : the Norwegian HUNT 2 study", BMC Public Health, 7, pp.220~ (2007)
198. Zabetian A, "Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions", Diabetes Res Clin Pract, 77, pp.251~257 (2007)
199. Pirkola J, "Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition", Arch Dis Child, 93, pp.945~951 (2008)
200. Brown TM, "Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?", J Womens Health (Larchmt), 17, pp.841~847 (2008)
201. Caprio S, "The metabolic phenotype of pre-diabetes in obese youth", Nutr Metab Cardiovasc Dis, 14, pp.270~275 (2004)
202. Cook S, "Growth curves for cardio-metabolic risk factors in children and adolescents", J Pediatr, 155, pp.S6~ (2009)
203. Cook S, "Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002", J Pediatr, 152, pp.165~170 (2008)
204. Gower BA, "Visceral fat, insulin sensitivity, and lipids in prepubertal children", Diabetes, 48, pp.1515~1521 (1999)
205. Gower BA, "Fat distribution and insulin response in prepubertal African American and white children", Am J Clin Nutr, 67, pp.821~827 (1998)
206. Cruz ML, "Insulin sensitivity and blood pressure in black and white children", Hypertension, 40, pp.18~22 (2002)
207. Ball GD, "Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty", J Pediatr, 148, pp.16~22 (2006)
208. Goran MI, "Influence of total vs. visceral fat on insulin action and secretion in African American and white children", Obes Res, 9, pp.423~431 (2001)
209. Arslanian S, "Insulin secretion and sensitivity in black versus white prepubertal healthy children", J Clin Endocrinol Metab, 82, pp.1923~1927 (1997)
210. Rodriguez BL, "Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study", Diabetes Care, 29, pp.1891~1896 (2006)
211. Linder B, "Research updates on type 2 diabetes children", NASN Sch Nurse, 28, pp.138~140 (2013)
212. Bell RA, "Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study", Diabetes Care, 32(Suppl 2), pp.S102~111 (2009)
213. Bobo N, "An update on type 2 diabetes in youth from the National Diabetes Education Program", Pediatrics, 114, pp.259~263 (2004)
214. Bosevski M, "Prevalence of metabolic syndrome components in the type 2 diabetic population who presented coronary artery disease", Prilozi, 28, pp.161~169 (2007)
215. Machado-Rodrigues AM, "Independent association of clustered metabolic risk factors with cardiorespiratory fitness in youth aged 11-17 years", Ann Hum Biol, 41, pp.271~276 (2014)
216. Ogden CL, "Prevalence and trends in overweight among US children and adolescents, 1999-2000", JAMA, 288, pp.1728~1732 (2002)
217. Ogden CL, "Prevalence of overweight among preschool children in the United States, 1971 through 1994", Pediatrics, 99, pp.E1~ (1997)
218. Ogden CL, "The epidemiology of obesity", Gastroenterology, 132, pp.2087~2102 (2007)
219. Troiano RP, "Overweight children and adolescents: description, epidemiology, and demographics", Pediatrics, 101(3 Pt 2), pp.497~504 (1998)
220. Flegal KM, "The effects of age categorization on estimates of overweight prevalence for children", Int J Obes Relat Metab Disord, 24, pp.1636~1641 (2000)
221. Whitaker RC, "Early adiposity rebound and the risk of adult obesity", Pediatrics, 101, pp.E5~ (1998)
222. Whitaker RC, "Predicting obesity in young adulthood from childhood and parental obesity", N Engl J Med, 337, pp.869~873 (1997)
223. Sun SS, "Childhood obesity predicts adult metabolic syndrome : the Fels Longitudinal Study", J Pediatr, 152, pp.191~200 (2008)
224. Must A, "Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935", N Engl J Med, 327, pp.1350~1355 (1992)
225. Steinberger J, "Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism)", Circulation, 107, pp.1448~1453 (2003)
226. Nadeau KJ, "Childhood obesity and cardiovascular disease : links and prevention strategies", Nat Rev Cardiol, 8, pp.513~525 (2011)
227. Smith SC Jr, "Discovering the full spectrum of cardiovascular disease : Minority Health Summit 2003 : report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group", Circulation, 111, pp.e134~9 (2005)
228. Janssen I, "Duration of overweight and metabolic health risk in American men and women", Ann Epidemiol, 14, pp.585~591 (2004)
229. St-Onge MP, "Metabolic syndrome in normal-weight Americans : new definition of the metabolically obese, normal-weight individual", Diabetes Care, 27, pp.2222~2228 (2004)
230. Sumner AE, "Validity of the reduced-sample insulin modified frequently-sampled intravenous glucose tolerance test using the nonlinear regression approach", Metabolism, 58, pp.220~225 (2009)
231. Mayer-Davis EJ, "Intensity and amount of physical activity in relation to insulin sensitivity : the Insulin Resistance Atherosclerosis Study", JAMA, 279, pp.669~674 (1998)
232. Srinivasan SR, "Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors : the Bogalusa Heart Study", Metabolism, 45, pp.235~240 (1996)
233. Maffeis C, "Insulin resistance and the persistence of obesity from childhood into adulthood", J Clin Endocrinol Metab, 87, pp.71~76 (2002)
234. Thivel D, "Metabolic syndrome in obese children and adolescents : dichotomous or continuous", Metab Syndr Relat Disord, 7, pp.549~555 (2009)
235. Katzmarzyk PT, "Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood : the Québec Family Study", J Clin Epidemiol, 54, pp.190~195 (2001)
236. Parsons TJ, "Childhood predictors of adult obesity : a systematic review", Int J Obes Relat Metab Disord, 23(Suppl 8), pp.S1~107 (1999)
237. Serdula MK, "Do obese children become obese adults? A review of the literature", Prev Med, 22, pp.167~177 (1993)
238. Dietz WH, "Health consequences of obesity in youth : childhood predictors of adult disease", Pediatrics, 101(3 Pt 2), pp.518~525 (1998)
239. Maria Felicia Faienza, "Childhood obesity, cardiovascular and liver health: a growing epidemic with age", World Journal of Pediatrics, 16(5), pp.438~445 (2020), Springer Science and Business Media LLC[DOI]
240. Faienza MF, "The dangerous link between childhood and adulthood predictors of obesity and metabolic syndrome", Intern Emerg Med, 11, pp.175~182 (2016)
241. Nolan PB, "Prevalence of metabolic syndrome and metabolic syndrome components in young adults : a pooled analysis", Prev Med Rep, 7, pp.211~215 (2017)
242. Parsons TJ, "Television viewing and obesity : a prospective study in the 1958 British birth cohort", Eur J Clin Nutr, 62, pp.1355~1363 (2008)
243. Freedman DS, "Childhood overweight and family income", MedGenMed, 9, pp.26~ (2007)
244. Tchernof A, "Pathophysiology of human visceral obesity : an update", Physiol Rev, 93, pp.359~404 (2013)
245. Michaud A, "Abdominal adipocyte populations in women with visceral obesity", Eur J Endocrinol, 174, pp.227~239 (2016)
246. Sniderman AD, "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis", Int J Epidemiol, 36, pp.220~225 (2007)
247. Haffner SM, "Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?", JAMA, 263, pp.2893~2898 (1990)
248. Lorenzo C, "Central adiposity determines prevalence differences of the metabolic syndrome", Obes Res, 11, pp.1480~1487 (2003)
249. Haffner SM, "Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects : implications for preventing coronary heart disease during the prediabetic state", Circulation, 101, pp.975~980 (2000)
250. Abbasi F, "Relationship between obesity, insulin resistance, and coronary heart disease risk", J Am Coll Cardiol, 40, pp.937~943 (2002)
251. Wagh A, "Treatment of metabolic syndrome", Expert Rev Cardiovasc Ther, 2, pp.213~228 (2004)
252. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration(BMI Mediated Effects), "Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke : a pooled analysis of 97 prospective cohorts with 1·8 million participants", Lancet, 383, pp.970~983 (2014)
253. Bassi N, "Lifestyle modification for metabolic syndrome : a systematic review", Am J Med, 127, pp.1242~ (2014)
254. Grundy SM, "Drug therapy of the metabolic syndrome : minimizing the emerging crisis in polypharmacy", Nat Rev Drug Discov, 5, pp.295~309 (2006)
255. DePaula AL, "Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus", Surg Endosc, 22, pp.2670~2678 (2008)
256. Danaei G, "The global cardiovascular risk transition : associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008", Circulation, 127, pp.1493~1502 (2013)
257. Wang HH, "Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones", Gastroenterology, 134, pp.2101~2110 (2008)
258. Conlon MA, "The impact of diet and lifestyle on gut microbiota and human health", Nutrients, 7, pp.17~44 (2014)
259. Cordain L, "Origins and evolution of the Western diet : health implications for the 21st century", Am J Clin Nutr, 81, pp.341~354 (2005)
260. Geleijnse JM, "Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations", Eur J Public Health, 14, pp.235~239 (2004)
261. Pacifico L, "Management of metabolic syndrome in children and adolescents", Nutr Metab Cardiovasc Dis, 21, pp.455~466 (2011)
262. Reinehr T, "Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence", Atherosclerosis, 207, pp.174~180 (2009)
263. Chen AK, "Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children", Metabolism, 55, pp.871~878 (2006)
264. Roberts CK, "Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors", Atherosclerosis, 191, pp.98~106 (2007)
265. Pasanisi F, "Benefits of sustained moderate weight loss in obesity", Nutr Metab Cardiovasc Dis, 11, pp.401~406 (2001)
266. Van Gaal LF, "The beneficial effects of modest weight loss on cardiovascular risk factors", Int J Obes Relat Metab Disord, 21(Suppl 1), pp.S5~9 (1997)
267. Stevens VJ, "Long-term weight loss and changes in blood pressure : results of the Trials of Hypertension Prevention, phase II", Ann Intern Med, 134, pp.1~11 (2001)
268. Case CC, "Impact of weight loss on the metabolic syndrome", Diabetes Obes Metab, 4, pp.407~414 (2002)
269. Mozaffarian D, "Changes in diet and lifestyle and long-term weight gain in women and men", N Engl J Med, 364, pp.2392~2404 (2011)
270. Ilanne-Parikka P, "Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study", Diabetes Care, 31, pp.805~807 (2008)
271. Forman D, "Cardiovascular disease : optimal approaches to risk factor modification of diet and lifestyle", Curr Treat Options Cardiovasc Med, 8, pp.47~57 (2006)
272. Stevens VJ, "Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group", Arch Intern Med, 153, pp.849~858 (1993)
273. Aucott L, "Effects of weight loss in overweight", obese individuals and long-term hypertension outcomes : a systematic review, 2005, pp.45, 1035~1041
274. Curioni CC, "Long-term weight loss after diet and exercise: a systematic review", Int J Obes(Lond), 29, pp.1168~1174 (2005)
275. Norris SL, "Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes : a meta-analysis", Am J Med, 117, pp.762~774 (2004)
276. Hofsø D, "Obesity-related cardiovascular risk factors after weight loss : a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention", Eur J Endocrinol, 163, pp.735~745 (2010)
277. Hamman RF, "Effect of weight loss with lifestyle intervention on risk of diabetes", Diabetes Care, 29, pp.2102~2107 (2006)
278. McAuley KA, "Intensive lifestyle changes are necessary to improve insulin sensitivity : a randomized controlled trial", Diabetes Care, 25, pp.445~452 (2002)
279. Franz MJ, "Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes : a systematic review and meta-analysis of randomized clinical trials", J Acad Nutr Diet, 115, pp.1447~1463 (2015)
280. Grundy SM, "Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance", Clin Cornerstone, 8(Suppl 1), pp.S21~27 (2006)
281. Wyszynski DF, "Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome(Genetic Epidemiology of Metabolic Syndrome Project)", Am J Cardiol, 95, pp.194~198 (2005)
282. Grundy SM, "Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?", Am J Med, 120(9 Suppl 1), pp.S3~8 (2007)
283. Grundy SM, "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines", J Am Coll Cardiol, 44, pp.720~732 (2004)
284. Grundy SM, "A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines", Arterioscler Thromb Vasc Biol, 24, pp.1329~1330 (2004)
285. See R, "Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population : observations from the Dallas Heart Study", Arch Intern Med, 168, pp.1055~1062 (2008)
286. Grundy SM, "United States Cholesterol Guidelines 2001 : expanded scope of intensive low-density lipoprotein-lowering therapy", Am J Cardiol, 88(7B), pp.23J~27J (2001)
287. Mozaffarian D, "Components of a cardioprotective diet : new insights", Circulation, 123, pp.2870~2891 (2011)
288. Astrup A, "Classification of obesity targeted personalized dietary weight loss management based on carbohydrate tolerance", Eur J Clin Nutr, 72, pp.1300~1304 (2018)
289. Chu L, "Effect of 7 days of exercise on exogenous carbohydrate oxidation and insulin resistance in children with obesity", Appl Physiol Nutr Metab, 43, pp.677~683 (2018)
290. Churuangsuk C, "Low-carbohydrate diets for overweight and obesity : a systematic review of the systematic reviews", Obes Rev, 19, pp.1700~1718 (2018)
291. Bailes JR, "Effect of low-carbohydrate, unlimited calorie diet on the treatment of childhood obesity : a prospective controlled study", Metab Syndr Relat Disord, 1, pp.221~225 (2003)
292. Foster GD, "A randomized trial of a low-carbohydrate diet for obesity", N Engl J Med, 348, pp.2082~2090 (2003)
293. Samaha FF, "A low-carbohydrate as compared with a low-fat diet in severe obesity", N Engl J Med, 348, pp.2074~2081 (2003)
294. Guthrie JF, "Food sources of added sweeteners in the diets of Americans", J Am Diet Assoc, 100, pp.43~51 (2000)
295. Dietz WH, "Sugar-sweetened beverages, milk intake, and obesity in children and adolescents", J Pediatr, 148, pp.152~154 (2006)
296. Dietz WH, "Television, obesity, and eating disorders", Adolesc Med, 4, pp.543~550 (1993)
297. Dowla S, "Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity : trial design and methodology", Contemp Clin Trials, 68, pp.95~101 (2018)
298. Hall KD, "Low-carbohydrate diets for the treatment of obesity and type 2 diabetes", Curr Opin Clin Nutr Metab Care, 21, pp.308~312 (2018)
299. Sartorius K, "Does high-carbohydrate intake lead to increased risk of obesity? A systematic review and meta-analysis", BMJ Open, 8, pp.e018449~ (2018)
300. Kaartinen NE, "Dietary carbohydrate quantity and quality in relation to obesity : a pooled analysis of three Finnish population-based studies", Scand J Public Health, 44, pp.385~393 (2016)
301. Sakurai M, "Dietary carbohydrate intake, presence of obesity and the incident risk of type 2 diabetes in Japanese men", J Diabetes Investig, 7, pp.343~351 (2016)
302. Sartorius B, "Carbohydrate intake, obesity, metabolic syndrome and cancer risk? A two-part systematic review and meta-analysis protocol to estimate attributability", BMJ Open, 6, pp.e009301~ (2016)
303. Halton TL, "Low-carbohydrate-diet score and the risk of coronary heart disease in women", N Engl J Med, 355, pp.1991~2002 (2006)
304. Frugé AD, "adults : 2007-2010 NHANES", Nutr Metab Cardiovasc Dis, 25, pp.535~540 (2015)
305. Cano-Ibáñez N, "Dietary intake in population with metabolic syndrome : is the prevalence of inadequate intake influenced by geographical area? Cross-sectional analysis from PREDIMED-Plus study", Nutrients, 10, pp.E1661~ (2018)
306. Navarro JCA, "Prevalence of metabolic syndrome and framingham risk score in apparently healthy vegetarian and omnivorous men", Arq Bras Cardiol, 110, pp.430~437 (2018)
307. de Mello Fontanelli M, "The relationship between carbohydrate quality and the prevalence of metabolic syndrome : challenges of glycemic index and glycemic load", Eur J Nutr, 57, pp.1197~1205 (2018)
308. Ma Y, "Association between carbohydrate intake and serum lipids", J Am Coll Nutr, 25, pp.155~163 (2006)
309. Liese AD, "Carbohydrate nutrition, glycaemic load, and plasma lipids : the Insulin Resistance Atherosclerosis Study", Eur Heart J, 28, pp.80~87 (2007)
310. Lewis CJ, "Nutrient intakes and body weights of persons consuming high and moderate levels of added sugars", J Am Diet Assoc, 92, pp.708~713 (1992)
311. Slyper AH, "The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity-an overview", J Pediatr Endocrinol Metab, 26, pp.617~629 (2013)
312. Tran BT, "The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults : results from the Korean National Health and Nutrition Examination Survey 2008-2013", BMC Public Health, 17, pp.71~ (2017)
313. Kastorini CM, "Metabolic syndrome, adherence to the Mediterranean diet and 10-year cardiovascular disease incidence : The ATTICA study", Atherosclerosis, 246, pp.87~93 (2016)
314. He DH, "Dietary patterns associated metabolic syndrome in Chinese adults", Biomed Environ Sci, 28, pp.370~373 (2015)
315. Lockard B, "Retrospective analysis of protein-and carbohydrate-focused diets combined with exercise on metabolic syndrome prevalence in overweight and obese women", Metab Syndr Relat Disord, 14, pp.228~237 (2016)
316. Yoo-Jin Um, "Dietary Fat Intake and the Risk of Metabolic Syndrome in Korean Adults", Korean Journal of Family Medicine, 36(5), pp.245~252 (2015), 대한가정의학회
317. Yubero-Serrano EM, "Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors : the LIPGENE study", Am J Clin Nutr, 102, pp.1509~1517 (2015)
318. Melanson EL, "The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome", Ann Nutr Metab, 55, pp.229~243 (2009)
319. Vessby B, "Dietary fat, fatty acid composition in plasma and the metabolic syndrome", Curr Opin Lipidol, 14, pp.15~19 (2003)
320. Ogden CL, "Prevalence of overweight and obesity in the United States, 1999-2004", JAMA, 295, pp.1549~1555 (2006)
321. Uusitupa M, "Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women", Am J Clin Nutr, 59, pp.1310~1316 (1994)
322. Julibert A, "Total and subtypes of dietary fat intake and its association with components of the metabolic syndrome in a mediterranean population at high cardiovascular risk", Nutrients, 11, pp.E1493~ (2019)
323. Vollmer WM, "New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products", Curr Control Trials Cardiovasc Med, 2, pp.71~74 (2001)
324. Bansal S, "Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women", JAMA, 298, pp.309~316 (2007)
325. Kris-Etherton P, "Summary of the scientific conference on dietary fatty acids and cardiovascular health : conference summary from the nutrition committee of the American Heart Association", Circulation, 103, pp.1034~1039 (2001)
326. Riccardi G, "Dietary fat, insulin sensitivity and the metabolic syndrome", Clin Nutr, 23, pp.447~456 (2004)
327. Hu FB, "Dietary fat intake and the risk of coronary heart disease in women", N Engl J Med, 337, pp.1491~1499 (1997)
328. Tierney AC, "Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study", Int J Obes(Lond), 35, pp.800~809 (2011)
329. Zoccali C, "Background dietary patterns and the time course of the blood pressure response to low sodium intake", Hypertension, 70, pp.890~892 (2017)
330. Sacks FM, "Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group", N Engl J Med, 344, pp.3~10 (2001)
331. Obarzanek E, "Effects on blood lipids of a blood pressure-lowering diet : the Dietary Approaches to Stop Hypertension(DASH)Trial", Am J Clin Nutr, 74, pp.80~89 (2001)
332. Vollmer WM, "Effects of diet and sodium intake on blood pressure : subgroup analysis of the DASH-sodium trial", Ann Intern Med, 135, pp.1019~1028 (2001)
333. Campanozzi A, "High sodium and low potassium intake among Italian children : relationship with age, body mass and blood pressure", PLoS One, 10, pp.e0121183~ (2015)
334. Campbell WW, "Higher total protein intake and change in total protein intake affect body composition but not metabolic syndrome indexes in middle-aged overweight and obese adults who perform resistance and aerobic exercise for 36 weeks", J Nutr, 145, pp.2076~2083 (2015)
335. Lutsey PL, "Dietary intake and the development of the metabolic syndrome : the Atherosclerosis Risk in Communities study", Circulation, 117, pp.754~761 (2008)
336. Van Elswyk ME, "A systematic review of renal health in healthy individuals associated with protein intake above the US recommended daily allowance in randomized controlled trials and observational studies", Adv Nutr, 9, pp.404~418 (2018)
337. Goran MI, "Metabolic precursors and effects of obesity in children : a decade of progress, 1990-1999", Am J Clin Nutr, 73, pp.158~171 (2001)
338. Bakker EA, "Association of resistance exercise, independent of and combined with aerobic exercise, with the incidence of metabolic syndrome", Mayo Clin Proc, 92, pp.1214~1222 (2017)
339. Bateman LA, "Comparison of aerobic versus resistance exercise training effects on metabolic syndrome(from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise-STRRIDE-AT", RT), 2011, pp.108, 838~844
340. Christ M, "Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome", Int J Cardiol, 97, pp.115~122 (2004)
341. Fatone C, "Two weekly sessions of combined aerobic and resistance exercise are sufficient to provide beneficial effects in subjects with Type 2 diabetes mellitus and metabolic syndrome", J Endocrinol Invest, 33, pp.489~495 (2010)
342. Kim JW, "Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women", Metab Syndr Relat Disord, 10, pp.452~457 (2012)
343. Yassine HN, "Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial", J Gerontol A Biol Sci Med Sci, 64, pp.90~95 (2009)
344. Tjønna AE, "Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome : a pilot study", Circulation, 118, pp.346~354 (2008)
345. Wewege MA, "Aerobic, resistance or combined training : a systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome", Atherosclerosis, 274, pp.162~171 (2018)
346. Johnson NA, "Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss", Hepatology, 50, pp.1105~1112 (2009)
347. Keating SE, "Effect of aerobic exercise training dose on liver fat and visceral adiposity", J Hepatol, 63, pp.174~182 (2015)
348. Christiansen T, "Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects : a 12-week randomized intervention study", Eur J Endocrinol, 160, pp.759~767 (2009)
349. Xiao T, "Resistance training vs. aerobic training and role of other factors on the exercise effects on visceral fat", Eur Rev Med Pharmacol Sci, 19, pp.1779~1784 (2015)
350. Oh S, "High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease", Sci Rep, 7, pp.43029~ (2017)
351. Yoshimura E, "Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity", J Obes, 2014, pp.197216~ (2014)
352. Lee S, "Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls : a randomized controlled trial", Am J Physiol Endocrinol Metab, 305, pp.E1222~9 (2013)
353. Thomas EL, "Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging", Lipids, 35, pp.769~776 (2000)
354. van der Heijden GJ, "A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents", Obesity(Silver Spring), 18, pp.384~390 (2010)
355. Ohkawara K, "A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials", Int J Obes(Lond), 31, pp.1786~1797 (2007)
356. Okura T, "Effects of aerobic exercise on metabolic syndrome improvement in response to weight reduction", Obesity(Silver Spring), 15, pp.2478~2484 (2007)
357. Ismail I, "A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat", Obes Rev, 13, pp.68~91 (2012)
358. Davis JN, "Interventions for improving metabolic risk in overweight Latino youth", Int J Pediatr Obes, 5, pp.451~455 (2010)
359. Haskell WL, "Physical activity and public health : updated recommendation for adults from the American College of Sports Medicine and the American Heart Association", Circulation, 116, pp.1081~1093 (2007)
360. Molina-Molina E, "Exercising the hepatobiliary-gut axis. The impact of physical activity performance", Eur J Clin Invest, 48, pp.e12958~ (2018)
361. Morales-Palomo F, "Effectiveness of aerobic exercise programs for health promotion in metabolic syndrome", Med Sci Sports Exerc, 51, pp.1876~1883 (2019)
362. Crist LA, "Influence of change in aerobic fitness and weight on prevalence of metabolic syndrome", Prev Chronic Dis, 9, pp.E68~ (2012)
363. Wang X, "Effects of a 12-month physical activity intervention on prevalence of metabolic syndrome in elderly men and women", J Gerontol A Biol Sci Med Sci, 67, pp.417~424 (2012)
364. Hashida R, "Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review", J Hepatol, 66, pp.142~152 (2017)
365. Robins SJ, "Cardiovascular disease with diabetes or the metabolic syndrome : should statins or fibrates be first line lipid therapy", Curr Opin Lipidol, 14, pp.575~583 (2003)
366. Scott R, "Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial", Cardiovasc Diabetol, 10, pp.102~ (2011)
367. Scott R, "Effects of fenofibrate treatment on cardiovascular disease risk in 9, 795 individuals with type 2 diabetes and various components of the metabolic syndrome : the Fenofibrate Intervention and Event Lowering in Diabetes(FIELD)study", Diabetes Care, 32, pp.493~498 (2009)
368. Burguera B, "What to offer the 99% of patients with severe obesity who do not undergo bariatric surgery", Mayo Clin Proc, 94, pp.957~960 (2019)
369. Younis A, "Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease", Cardiovasc Diabetol, 15, pp.149~ (2016)
370. Tenenbaum A, "Which is the best lipid-modifying strategy in metabolic syndrome and diabetes : fibrates, statins or both", Cardiovasc Diabetol, 3, pp.10~ (2004)
371. Tenenbaum A, "Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes : therapeutic options beyond statins", Cardiovasc Diabetol, 5, pp.20~ (2006)
372. Kastelein JJ, "Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment", Circulation, 117, pp.3002~3009 (2008)
373. Keaney JF Jr, "A pragmatic view of the new cholesterol treatment guidelines", N Engl J Med, 370, pp.275~278 (2014)
374. Bays HE, "National Lipid Association Annual Summary of Clinical Lipidology 2015", J Clin Lipidol, 8(6 Suppl), pp.S1~36 (2014)
375. Jacobson TA, "Combination lipid-altering therapy : an emerging treatment paradigm for the 21st century", Curr Atheroscler Rep, 3, pp.373~382 (2001)
376. Robins SJ, "Insulin resistance and cardiovascular events with low HDL cholesterol : the Veterans Affairs HDL Intervention Trial(VA-HIT)", Diabetes Care, 26, pp.1513~1517 (2003)
377. Dujovne CA, "What combination therapy with a statin, if any, would you recommend", Curr Atheroscler Rep, 13, pp.12~22 (2011)
378. Boden WE, "Raising low levels of high-density lipoprotein cholesterol is an important target of therapy", Am J Cardiol, 85, pp.645~650 (2000)
379. AIM-HIGH Investigators, "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy", N Engl J Med, 365, pp.2255~2267 (2011)
380. Jacobson TA, "Combination lipid-lowering therapy with statins : safety issues in the postcerivastatin era", Expert Opin Drug Saf, 2, pp.269~286 (2003)
381. Blaha MJ, "The importance of non-HDL cholesterol reporting in lipid management", J Clin Lipidol, 2, pp.267~273 (2008)
382. Jacobson TA, "National lipid association recommendations for patient-centered management of dyslipidemia : part 1--full report", J Clin Lipidol, 9, pp.129~169 (2015)
383. Windler E, "Current strategies and recent advances in the therapy of hypercholesterolemia", Atheroscler Suppl, 10, pp.1~4 (2009)
384. ACCORD Study Group, "Effects of combination lipid therapy in type 2 diabetes mellitus", N Engl J Med, 362, pp.1563~1574 (2010)
385. Robins SJ, "Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome", Curr Cardiol Rep, 7, pp.457~464 (2005)
386. Diabetes Prevention Program Research Group, "10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study", Lancet, 374, pp.1677~1686 (2009)
387. American Diabetes Association, "Standards of medical care in diabetes--2014", Diabetes Care, 37(Suppl 1), pp.S14~80 (2014)
388. Alsumali A, "Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity", Surg Obes Relat Dis, 14, pp.1041~1059 (2018)
389. Busetto L, "Timing of bariatric surgery in people with obesity and diabetes", Ann Transl Med, 3, pp.94~ (2015)
390. Busetto L, "Obesity Management Task Force of the European Association for the Study of Obesity Released"Practical Recommendations for the Post-Bariatric Surgery Medical Management"", Obes Surg, 28, pp.2117~2121 (2018)
391. Busetto L, "Practical recommendations of the obesity management task force of the European association for the study of obesity for the post-bariatric surgery medical management", Obes Facts, 10, pp.597~632 (2017)
392. Busetto L, "Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders(IFSO)", Obes Surg, 24, pp.487~519 (2014)
393. Mechanick JI, "Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures-2019 update : cosponsored by American Association of Clinical Endocrinologists", American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists, 2020, pp.16, 175~247
394. Rega-Kaun G, "Roux-en-Y-bariatric surgery reduces markers of metabolic syndrome in morbidly obese patients", Obes Surg, 30, pp.391~400 (2020)
395. Jennifer Reiter-Purtill, "Change, predictors and correlates of weight- and health-related quality of life in adolescents 2-years following bariatric surgery", International Journal of Obesity (2019), Springer Science and Business Media LLC[DOI]
396. Mital S, "Incremental cost-effectiveness of aspiration therapy vs bariatric surgery and no treatment for morbid obesity", Am J Gastroenterol, 114, pp.1470~1477 (2019)
397. Wee CC, "Sex, race, and consideration of bariatric surgery among primary care patients with moderate to severe obesity", J Gen Intern Med, 29, pp.68~75 (2014)
398. Dixon JB, "Bariatric surgery : an IDF statement for obese Type 2 diabetes", Diabet Med, 28, pp.628~642 (2011)
399. Allen SR, "Attitudes of bariatric surgeons concerning adolescent bariatric surgery(ABS)", Obes Surg, 15, pp.1192~1195 (2005)
400. Desai NK, "Update on adolescent bariatric surgery", Endocrinol Metab Clin North Am, 45, pp.667~676 (2016)
401. Al-Qahtani AR, "Laparoscopic adjustable gastric banding in adolescent : safety and efficacy", J Pediatr Surg, 42, pp.894~897 (2007)
402. O'Brien PE, "Bariatric surgery : mechanisms, indications and outcomes", J Gastroenterol Hepatol, 25, pp.1358~1365 (2010)
403. Horgan S, "Laparoscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the United States : a safe alternative to gastric bypass", J Pediatr Surg, 40, pp.86~90 (2005)
404. Inge TH, "A multidisciplinary approach to the adolescent bariatric surgical patient", J Pediatr Surg, 39, pp.442~447 (2004)
405. Breaux CW, "Obesity surgery in children", Obes Surg, 5, pp.279~284 (1995)
406. Strauss RS, "Gastric bypass surgery in adolescents with morbid obesity", J Pediatr, 138, pp.499~504 (2001)
407. Stanford A, "Laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents", J Pediatr Surg, 38, pp.430~433 (2003)
408. Sugerman HJ, "Bariatric surgery for severely obese adolescents", J Gastrointest Surg, 7, pp.102~108 (2003)
409. Fernandez AZ Jr, "Experience with over 3, 000 open and laparoscopic bariatric procedures : multivariate analysis of factors related to leak and resultant mortality", Surg Endosc, 18, pp.193~197 (2004)
410. Helmrath MA, "Adolescent obesity and bariatric surgery", Surg Clin North Am, 86, pp.441~454 (2006)
411. Goldschmidt AB, "Adolescent loss-of-control eating and weight loss maintenance after bariatric surgery", Pediatrics, 141, pp.e20171659~ (2018)
412. Inge TH, "Comparative effectiveness of bariatric procedures among adolescents : the PCORnet bariatric study", Surg Obes Relat Dis, 14, pp.1374~1386 (2018)
413. Bianciardi E, "Body image dissatisfaction in individuals with obesity seeking bariatric surgery : exploring the burden of new mediating factors", Riv Psichiatr, 54, pp.8~17 (2019)
414. Price PH, "Physical activity improves lipid and weight-loss outcomes after metabolic bariatric surgery in adolescents with severe obesity", Obesity(Silver Spring), 27, pp.989~996 (2019)
415. Tsai WS, "Bariatric surgery in adolescents : recent national trends in use and in-hospital outcome", Arch Pediatr Adolesc Med, 161, pp.217~221 (2007)
416. Inge TH, "Managing bariatric patients in a children's hospital : radiologic considerations and limitations", J Pediatr Surg, 40, pp.609~617 (2005)
417. Stefater MA, "Bariatric surgery for adolescents with Type 2 diabetes : an emerging therapeutic strategy", Curr Diab Rep, 17, pp.62~ (2017)
418. Coutant R, "Bariatric surgery in adolescents with severe obesity: Review and state of the art in France", Ann Endocrinol(Paris), 78, pp.462~468 (2017)
419. Canoy D, "Obesity in children : bariatric surgery", BMJ Clin Evid, 2015, pp.0325~ (2015)
420. Borgès Da Silva V, "Association between binge eating disorder and psychiatric comorbidity profiles in patients with obesity seeking bariatric surgery", Compr Psychiatry, 87, pp.79~83 (2018)
421. Field AE, "Association of obesity subtypes in the longitudinal assessment of bariatric surgery study and 3-year postoperative weight change", Obesity(Silver Spring), 26, pp.1931~1937 (2018)
422. Ryder JR, "Factors associated with long-term weight-loss maintenance following bariatric surgery in adolescents with severe obesity", Int J Obes(Lond), 42, pp.102~107 (2018)
423. Michalsky MP, "Cardiovascular risk factors after adolescent bariatric surgery", Pediatrics, 141, pp.e20172485~ (2018)
424. Inge TH, "Bariatric surgery for severely overweight adolescents : concerns and recommendations", Pediatrics, 114, pp.217~223 (2004)
425. O'Brien PE, "Controversies in bariatric surgery", Br J Surg, 102, pp.611~618 (2015)
426. O'Brien PE, "Long-term outcomes after bariatric surgery : a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding", Obes Surg, 29, pp.3~14 (2019)
427. O'Brien PE, "Long-term outcomes after bariatric surgery : fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature", Ann Surg, 257, pp.87~94 (2013)
428. O'Brien PE, "Systematic review of medium-term weight loss after bariatric operations", Obes Surg, 16, pp.1032~1040 (2006)
429. van Geelen SM, "The controversy over pediatric bariatric surgery : an explorative study on attitudes and normative beliefs of specialists, parents, and adolescents with obesity", J Bioeth Inq, 10, pp.227~237 (2013)
430. Epstein LH, "Growth in obese children treated for obesity", Am J Dis Child, 144, pp.1360~1364 (1990)
431. Epstein LH, "Ten-year follow-up of behavioral, family-based treatment for obese children", JAMA, 264, pp.2519~2523 (1990)
432. Valoski A, "Nutrient intake of obese children in a family-based behavioral weight control program", Int J Obes, 14, pp.667~677 (1990)
433. Xanthakos SA, "Nutritional risks in adolescents after bariatric surgery", Clin Gastroenterol Hepatol, 18, pp.1070~1081 (2020)
434. Anker SD, "Weight loss and health status after bariatric surgery in adolescents", N Engl J Med, 374, pp.1988~ (2016)
435. Inge TH, "Long-term outcomes of bariatric surgery in adolescents with severe obesity(FABS-5+) : a prospective follow-up analysis", Lancet Diabetes Endocrinol, 5, pp.165~173 (2017)
436. Hofmann B, "Bariatric surgery for obese children and adolescents : a review of the moral challenges", BMC Med Ethics, 14, pp.18~ (2013)
437. Black JA, "Bariatric surgery for obese children and adolescents : a systematic review and meta-analysis", Obes Rev, 14, pp.634~644 (2013)
438. Cruz ML, "The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity", J Clin Endocrinol Metab, 89, pp.108~113 (2004)
439. Ford ES, "The metabolic syndrome and concentrations of C-reactive protein among U.S. youth", Diabetes Care, 28, pp.878~881 (2005)
440. Viner RM, "Prevalence of the insulin resistance syndrome in obesity", Arch Dis Child, 90, pp.10~14 (2005)
441. Mellerio H, "Novel modeling of reference values of cardiovascular risk factors in children aged 7 to 20 years", Pediatrics, 129, pp.e1020~9 (2012)

관련 논문AI추천